glp 1 stomach acid GLP-1 Medicines And Gut Bacterial Overgrowth GLP-1 receptor agonists and delayed

As soon as January 2026, companies like Sandoz and Apotex are expected to launch generic versions of semaglutide in Canada, where protections from data exclusivity will come to an end

Peptide receptor radionuclide therapy for patients with advanced lung carcinoids

Clin Pharmacokinet 58(9):11931203 Bogman K, Brumm J, Hofmann C, Giraudon M, Niggli M, Sturm-Pellanda C et al (2019) Assessment of drug-drug interactions between taspoglutide, a glucagon-like peptide-1 agonist, and drugs commonly used in type 2 diabetes mellitus: results of five phase I trials

In addition, SanovaWorks offers the online and audio-format Derm in Review , a board certification and recertification course